Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.

OBJECTIVE: Though effective anti-human immunodeficiency virus (HIV) therapies are now available, they have variable penetration into the brain. We therefore aimed to assess changes over calendar time in the risk for HIV-associated dementia (HIV-D), and factors associated with HIV-D risk. METHODS: Us...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Bhaskaran, K, Mussini, C, Antinori, A, Walker, A, Dorrucci, M, Sabin, C, Phillips, A, Porter, K
Format:	Journal article
Język:	English
Wydane:	2008

Podobne zapisy

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
od: Marin, B, i wsp.
Wydane: (2009)

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
od: Wolbers, M, i wsp.
Wydane: (2010)

Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
od: Sridharan Sudharshan, i wsp.
Wydane: (2020-01-01)

Pulmonary toxoplasmosis in human immunodeficiency virus-infected patients in the era of antiretroviral therapy
od: Jorge N Velásquez, i wsp.
Wydane: (2016-01-01)

Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
od: Bhaskaran, K, i wsp.
Wydane: (2004)

Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy.
od: Doerholt, K, i wsp.
Wydane: (2006)

Ocular Manifestations of Human Immunodeficiency Virus Infection in the Combination Antiretroviral Therapy Era
od: Mingming Yang, i wsp.
Wydane: (2023-12-01)

Reversal of acquired immunodeficiency syndrome-dementia complex with antiretroviral therapy
od: Kamalam Iyer, i wsp.
Wydane: (2007-01-01)

Combination Antiretroviral Therapy and Immunophenotype of Feline Immunodeficiency Virus
od: Jeffrey Kim, i wsp.
Wydane: (2023-03-01)

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
od: International Collaboration on HIV and Cancer
Wydane: (2000)

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
od: Marcel Wolbers, i wsp.
Wydane: (2010-02-01)

Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) <it>in vitro </it>and Simian Immunodeficiency virus (SIV) <it>ex vivo</it>
od: Borojerdi Jennifer P, i wsp.
Wydane: (2009-11-01)

Antiretroviral agents against human immunodeficiency virus
od: Ingrid Barcelos de Oliveira, i wsp.
Wydane: (2022-01-01)

Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities
od: Julio C. Abarca, i wsp.
Wydane: (2020-03-01)

Oral Candida flora from Brazilian human immunodeficiency virus-infected patients in the highly active antiretroviral therapy era
od: NR Melo, i wsp.
Wydane: (2004-06-01)

Epidemiology and Outcomes in Critically Ill Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy
od: Shannon L. Turvey, i wsp.
Wydane: (2017-01-01)

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
od: Cristina Mussini, i wsp.
Wydane: (2015-01-01)

Incidence rate of mortality and its predictors among tuberculosis and human immunodeficiency virus coinfected patients on antiretroviral therapy in Ethiopia: systematic review and meta-analysis
od: Nebiyu Mekonnen Derseh, i wsp.
Wydane: (2024-04-01)

Genetic diversity of human immunodeficiency viruses and antiretroviral therapy
od: M R Bobkova
Wydane: (2016-11-01)

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
od: Touloumi, G, i wsp.
Wydane: (2006)

Predictors of adherence to antiretroviral therapy among human immunodeficiency virus patients in Jos University Teaching Hospital, Nigeria
od: Panmial, P. D., i wsp.
Wydane: (2019)

Use of Non-Prescription Remedies by Ghanaian Human Immunodeficiency Virus-Positive Persons on Antiretroviral Therapy
od: Amos K. Laar, i wsp.
Wydane: (2017-05-01)

Prevalence of emphysema in people living with human immunodeficiency virus in the current combined antiretroviral therapy era: A systematic review
od: Hedda Ringheim, i wsp.
Wydane: (2022-09-01)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
od: Sinha Rajesh, i wsp.
Wydane: (2008-01-01)

Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan
od: Yi-Chieh Lee, i wsp.
Wydane: (2018-02-01)

Implications for a policy of initiating antiretroviral therapy in people diagnosed with human immunodeficiency virus: the CAPRA research programme
od: Ada Miltz, i wsp.
Wydane: (2017-10-01)

Antiretroviral activity of Pterois volitans (red lionfish) venom in the early development of human immunodeficiency virus/acquired immunodeficiency syndrome antiretroviral alternative source
od: Andy Noorsaman Sommeng, i wsp.
Wydane: (2019-02-01)

Infection with human immunodeficiency virus is an independent predictor of increased aortic stiffness
od: Asaad, M, i wsp.
Wydane: (2012)

Incidence and predictors of attrition among human immunodeficiency virus infected children on antiretroviral therapy in Amhara comprehensive specialized hospitals, Northwest Ethiopia, 2022: a retrospective cohort study
od: Alemu Birara Zemariam, i wsp.
Wydane: (2024-02-01)

Double-Negative T-Cells during Acute Human Immunodeficiency Virus and Simian Immunodeficiency Virus Infections and Following Early Antiretroviral Therapy Initiation
od: Alexis Yero, i wsp.
Wydane: (2024-10-01)

Central nervous system manifestations in human immunodeficiency virus patients in the antiretroviral therapy era - Scenario from a developing country
od: Jency Maria Koshy, i wsp.
Wydane: (2015-01-01)

Cognitive impairment and antiretroviral treatment in a Peruvian population of patients with human immunodeficiency virus
od: E.A. Guevara-Silva
Wydane: (2014-05-01)

Advances in Antiretroviral Therapy for Patients with Human Immunodeficiency Virus-Associated Tuberculosis
od: Xiaoqin Le, i wsp.
Wydane: (2024-03-01)

Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (Haart)
od: N. Sunil Kumar, i wsp.
Wydane: (2015-07-01)

Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients
od: Dishank Patel, i wsp.
Wydane: (2013-01-01)

An Intelligent Multicriteria Model for Diagnosing Dementia in People Infected with Human Immunodeficiency Virus
od: Luana I. C. C. Pinheiro, i wsp.
Wydane: (2021-11-01)

Oral manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome and their correlation to cluster of differentiation lymphocyte count in population of North-East India in highly active antiretroviral therapy era
od: Sarat Kumar Nayak, i wsp.
Wydane: (2016-01-01)

PREDICTORS OF CHRONICKIDNEY DISEASEINHUMAN IMMUNODEFICIENCY VIRUS PATIENTS
od: M.O. Andrushchak
Wydane: (2018-03-01)

Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.
od: Iversen, A, i wsp.
Wydane: (1996)

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
od: Ledergerber, B, i wsp.
Wydane: (2004)